JSC Evex Hospitals

Tbilisi 4600

0 studies enrolling now · 8 studies all time

What they study most

Arthritis, Psoriatic, Arthritis, Rheumatoid, Chronic Gout, Gout, Gout Flare, Hyperuricemia, Immunoglobulin A (IgA) Nephropathy, Neovascular Age-Related Macular Degeneration, Squamous Cell Carcinoma of the Head and Neck, Staphylococcal Infections, Surgical Site Infection, Tophi

Studies at this site

• A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
• Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II — Completed
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor — Completed
• Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection — Completed